Intratumoral heterogeneity in programmed death‐ligand 1 immunoreactivity is associated with variation in non‐small cell lung carcinoma histotype-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intratumoral heterogeneity in programmed death‐ligand 1 immunoreactivity is associated with variation in non‐small cell lung carcinoma histotype

Published:2019-12-23 Issue:3 Volume:76 Page:394-403
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Naso Julia R¹^ORCID,Wang Gang²^ORCID,Pender Alexandra³,Wong Selina K³,Zhu Jingyao⁴,Ho Cheryl³,Ionescu Diana N²,Zhou Chen²

Affiliation:

1. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver BC Canada

2. Department of Pathology British Columbia Cancer Agency Vancouver BC Canada

3. Department of Medical Oncology British Columbia Cancer Agency Vancouver BC Canada

4. Department of Microbiology and Immunology University of British Columbia Vancouver BC Canada

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.13983

Reference34 articles.

1. PD-1/PD-L1 blockade in cancer treatment: perspectives and issues

2. Predictive markers for anti-PD-1/PD-L1 therapy in non-small cell lung cancer—where are we?

3. FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond

4. Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy

5. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic profile characterization of histological micropapillary and solid components in lung adenocarcinoma: a systematic review;Journal of Laboratory and Precision Medicine;2024-07

2. PD‐L1 expression in resected lung adenocarcinoma: prevalence and prognostic significance in relation to the IASLC grading system;Histopathology;2024-01-30

3. Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China;Annals of Surgical Oncology;2023-09-01

4. Clinical efficacy and safety of adjuvant EGFR‐TKIs for resected stage IB lung adenocarcinoma: A real‐world study based on propensity score matching;Cancer Medicine;2023-08-09

5. Relationship between PD-L1 expression and molecular aberrances in lung adenocarcinoma with solid components;Journal of Thoracic Disease;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3